SCHEMBL6445501

SCHEMBL6445501

CC(C)(C)OC(=O)Nc1ccccc1NC(=O)c1cc2cccc(OCCC3CCCN3)c2o1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AA1 P07900 1/20 0.41
HSP90AB1 P08238 1/20 0.41
UGCG Q16739 2/20 0.40
NPC1 O15118 3/20 0.39
RAB9A P51151 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
CNR2 P34972 4/20 0.38
MKNK1 Q9BUB5 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
CHRM3 P20309 1/20 0.36
ALDH1A1 P00352 2/20 0.36
GLA P06280 1/20 0.36
KMT2A Q03164 1/20 0.36
DRD2 P14416 1/20 0.36
DRD3 P35462 1/20 0.36
KDM4E B2RXH2 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6448061 0.98 HSP90AA1 (0.44) HSP90AA1HSP90AB1UGCGNPC1RAB9A
SCHEMBL5564059 0.83 NPC1 (0.47) NPC1RAB9ASMN1; SMN2L3MBTL1CNR2
SCHEMBL5563050 0.83 RXFP1 (0.45) UGCGNPC1RAB9ASMN1; SMN2L3MBTL1
SCHEMBL5564192 0.82 RXFP1 (0.46) UGCGNPC1SMN1; SMN2HRH3ALDH1A1
SCHEMBL5565724 0.81 NPC1 (0.44) NPC1RAB9ASMN1; SMN2L3MBTL1CNR2
SCHEMBL5564847 0.81 RXFP1 (0.44) UGCGNPC1RAB9ASMN1; SMN2L3MBTL1
SCHEMBL5564958 0.80 RXFP1 (0.45) UGCGNPC1RAB9ASMN1; SMN2L3MBTL1
SCHEMBL5559654 0.80 RXFP1 (0.54) NPC1CNR2ALDH1A1KMT2ADRD2
SCHEMBL5563555 0.79 RAB9A (0.44) NPC1RAB9ASMN1; SMN2L3MBTL1CNR2
SCHEMBL5566157 0.79 RAB9A (0.41) UGCGNPC1RAB9ASMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1594857-A2 N-MONOACYLATED O-PHENYLENEDIAMINES AS ANTI-CANCER AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2005-11-16 EP disclosed
WO-2004069133-A2 N-MONOACYLATED O-PHENYLENEDIAMINES AS ANTI -CANCER AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2004-08-19 WO disclosed